Abnormal clinical presentation in Group A included altered pigmentation ( 35.6 % ) , rapid enlargement ( 30.5 % ) , keratotic changes ( 16.9 % ) , inflammation ( 7.6 % ) , ulceration ( 5.1 % ) , and hemorrhage ( 4.2 % ) .